Rhumbline Advisers Artivion, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Artivion, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 118,836 shares of AORT stock, worth $3.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,836
Previous 122,687
3.14%
Holding current value
$3.45 Million
Previous $2.6 Million
17.41%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AORT
# of Institutions
163Shares Held
35.2MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$193 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$81.7 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$81.2 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$80.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$68.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.17B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...